ERIVEDGE (Genentech, Inc.)
Welcome to the PulseAid listing for the ERIVEDGE drug offered from Genentech, Inc.. This Hedgehog Pathway Inhibitor [EPC],Smoothened Receptor Antagonists [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Genentech, Inc. |
| NON-PROPRIETARY NAME: | vismodegib |
| SUBSTANCE NAME: | VISMODEGIB |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Hedgehog Pathway Inhibitor [EPC],Smoothened Receptor Antagonists [MoA] |
| ROUTE: | ORAL |
| DOSAGE FORM: | CAPSULE |
| MARKETING CATEGORY NAME: | NDA |
| START MARKETING DATE: | 2012-01-30 |
| END MARKETING DATE: | 0000-00-00 |
ERIVEDGE HUMAN PRESCRIPTION DRUG Details:
| Item Description | ERIVEDGE from Genentech, Inc. |
| LABELER NAME: | Genentech, Inc. |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 150(mg/1) |
| START MARKETING DATE: | 2012-01-30 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 50242-140_ae126691-df0d-4ac6-bc56-5a3566d1f225 |
| PRODUCT NDC: | 50242-140 |
| APPLICATION NUMBER: | NDA203388 |
Other VISMODEGIB Pharmaceutical Manufacturers / Labelers:
